2010 Annual Meeting | Autoimmune Testing in Neuropathy: Indications for the Practicing Clinician

Date Saturday 04/16/11

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Kenneth C. Gorson, MD

Topic(s)

Learning Objectives Participants should have a greater understanding of the appropriate indications for ordering autoantibodies in the evaluation of patients with peripheral neuropathy.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
06:45 AM - 08:30 AM		Breakfast
07:00 AM - 07:45 AM		Polyneuropathy Syndromes Associated with Anti-Mag, Anti-Hu, and Ganglionic Nicotinic Antibodies Kenneth C. Gorson, MD
07:45 AM - 08:30 AM		Indications for Anti-ganglioside and anti-Sulfatide Antibody Testing Eduardo Nobile-Orazio, MD, PhD, FAAN

Faculty Disclosures
Kenneth C. Gorson, MD	Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Gorson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Gorson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Eduardo Nobile-Orazio, MD, PhD, FAAN	Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.